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ABSTRACT Myelin protein zero (P0 or P0 glycoprotein), the major integral membrane protein in peripheral nervous system
myelin, plays a key role in myelin membrane compaction and stability. While the structure of P0 extracellular domain was
determined by crystallography, the paucity of any structural data on the highly positive-charged P0 cytoplasmic domain (P0-cyt)
has greatly limited our understanding of the mechanism of P0 function. Here, using circular dichroism and intrinsic ﬂuorescence
spectroscopy, we attempted to elucidate the structure of human P0-cyt (hP0-cyt) in membrane mimetic environments com-
posed of detergents or lipid vesicles. We found that the secondary structure of P0-cyt was polymorphic—at the lipid/protein ratio
corresponding to that of mature peripheral myelin (;50:1), hP0-cyt mainly adopted a b-conformation, whereas when the pro-
portion of lipid increased, the structure underwent a b/a transition. By contrast, the secondary structure of the major isoform of
myelin basic protein, another myelin protein with a very large positive charge, remained unchanged across a wide range of lipid/
protein ratios. We propose that when hP0-cyt is bound at sufﬁcient concentration to lamellar lipid bilayers such as myelin, it folds
into a b-conformation; before this threshold lipid/protein ratio is reached, the domain is a-helical. We suggest that the cyto-
plasmic apposition (major dense line) in compact myelin may be stabilized via the hydrogen-bonding of b-strands formed as a
result of local P0-P0 aggregation.
INTRODUCTION
Myelin protein zero (P0), an integral glycoprotein, is the
major protein in peripheral nervous systemmyelin (1). P0 is a
single-pass transmembrane protein with a 124-residue disul-
ﬁde-stabilized VH-like extracellular domain (2–4) and a
highly basic, 69-residue cytoplasmic domain (P0-cyt). As a
cell adhesion molecule, P0 serves as the structural cement in
peripheral nervous system myelin (5), playing a key role
in the compaction and stability of both extracellular and
cytoplasmic surfaces of the myelin membrane. Mutations in
MPZ, the gene for this protein, can cause serious neurological
disorders, including Charcot-Marie-Tooth disease type 1B,
Dejerine-Sottas syndrome (DSS), and congenital hypomye-
lination neuropathy (4,6), presumably either by disrupting the
normal myelin architecture throughmisfolding of the myelin-
incorporated mutated P0, or by disrupting the normal bio-
synthesis of the myelin. In either case, myelin membrane
structure and intermembrane interactions are altered. Inter-
membrane interactions are accounted for by a balance
between repulsive electrostatic interactions and attractive
van der Waals interactions (7) and based on the theory of
colloid stability developed by Derjaguin, Landau, Verwey,
andOverbeek (referred to as DLVO theory) (8). As examples,
the swelling and compaction at the extracellular apposition of
peripheral nervous system myelin as a function of pH and
ionic strength can be largely explained by such consider-
ations, as can the discontinuous myelin compaction of the
extracellular apposition at physiological pH and ionic
strength, which may be due to an ionic interaction of the P0
extracellular domain involving His-52 and Arg-45 (9,10). By
contrast, the mechanism underlying the invariance of the
narrow cytoplasmic apposition of peripheral nervous system
myelin to a wide range of pH values and ionic strengths (9,11)
remains unexplained.
Solution scattering of full-length P0 in a membrane lipid
mimetic (1–8 mg protein/ml in 0.1% sodium dodecylsulfate,
SDS) (12) suggests that like the extracellular domain in
crystals (that form from protein at ;30 mg/ml) (10) the en-
tire molecule also assembles tetramerically. Thus, the folded
cytoplasmic domain of P0, whose structure at atomic reso-
lution has not yet been solved crystallographically, must
conform to the overall tetrameric assembly and also ﬁt into
the narrow intermembrane gap at the cytoplasmic apposition.
Using circular dichroism (CD) and intrinsic ﬂuorescence
spectroscopies, we carried out systematic studies on hu-
man P0-cyt (hP0-cyt) structure in membrane mimetic envi-
ronments. Our experiments addressed the structure of the
protein at concentrations that were ;10 to 1000-fold less
than the concentration at which the tetramers form. We ﬁrst
studied the protein folding in membrane-mimicking deter-
gents including zwitterionic dodecylphosphocholine (DPC),
micellar SDS, and a low dielectric organic solvent 2,2,
2-triﬂuoroethanol (TFE). We further simulated the native en-
vironment of hP0-cyt by using small unilamellar lipid vesicles
(SUVs) made of phosphatidylcholine (PC) and phosphatidyl-
serine (PS). Our results suggest a novel secondary structure
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change of hP0-cyt as a function of the relative proportion of
membrane lipid and protein constituents. In aqueous buffer
or at lipid/protein mole ratios ,;50:1 (which is the level in
peripheral nervous system myelin), hP0-cyt maintained a
b-conformation, whereas when the ratio increased (i.e., con-
centration of lipid or detergent increases), a b/a transition
occurred. By contrast, under similar experimental conditions
the 18.5 kDa isoform of bovine myelin basic protein (bMBP),
another key protein in the cytoplasmic apposition of myelin
sheaths, did not show a similar trend in structural changes.
Vesicles made of negative-charged PS or phosphatidylino-
sitol (PI), which were examined to study the charge effect of
lipid on the structures of hP0-cyt and bMBP, maintained
similar secondary structures as compared with those of the
proteins in aqueous buffer.
EXPERIMENTAL PROCEDURES
SDS and TFE were obtained from Sigma (St. Louis, MO). DPC, egg PC,
brain PS, bovine liver PI, and cholesterol were obtained from Avanti Polar
Lipids (Alabaster, AL). Dephosphorylated 18.5 kDa bMBP was obtained
from Upstate (Charlottesville, VA).
Peptide synthesis
The 69-residue-long hP0-cyt peptide was synthesized at the Department of
Molecular Biochemistry and Pharmacology, Institute for Pharmacologi-
cal Research ‘‘Mario Negri,’’ Milan, Italy, using the solid-phase peptide
synthesis method (13). The peptide was puriﬁed by reverse-phase HPLC,
and its integrity determined by MALDI-TOF. The purity of the peptide used
in this study was .95%.
Preparation of lipid vesicles
The vesicles were prepared according to published procedures, and are
reported to be 40 nm in diameter (14). Brieﬂy, PS, or PI, or a mixture of PC
and PS (molar ratio 12:1) or PC, PS, and cholesterol (molar ratio 62:5:33),
were dissolved in pure chloroform and dried under a gentle stream of N2 gas
to form a lipid ﬁlm, and further dried under high vacuum overnight. The
dried lipid ﬁlm was hydrated in an aqueous buffer to form a lipid suspension.
Small, unilamellar vesicles (SUVs) were produced by sonicating the lipid
suspension in an ice-water bath using an ultrasonic homogenizer equipped
with a microtip probe (Cole-Parmer Instrument, Chicago, IL) until the
solution became translucent. Titanium particles shed by the ultrasonic probe
into the solution were removed by centrifugation. Total lipid concentration
in lipid vesicles ranged from 0.1–4 mg/ml for CD and ﬂuorescence spec-
troscopy studies and 25 mg/ml for small-angle x-ray diffraction.
Circular dichroism (CD) spectroscopy
All CD samples were prepared in phosphate-buffered saline (PBS) unless
otherwise noted. All data were acquired on an AVIV Model 202 Circular
Dichroism Spectropolarimeter (Lakewood, NJ). Samples of vesicles made of
PS or PI alone were made in 0.5 mM Tris-HCl, pH 7.4, instead of PBS to
avoid turbidity caused by protein-induced vesicle aggregation. Spectra were
recorded in a 0.1-cm path-length rectangular quartz cell at 25C from 260
nm to 195 nmwith 1 nm increments and an averaging time of one second per
data point. For all CD measurements, protein concentration was 20 mM for
hP0-cyt, and 10 mM for myelin basic protein (MBP). Five to seven scans
for each sample were averaged, smoothed using the inverse exponential
method, and plotted using SigmaPlot 2001 (Systat Software, Richmond,
CA). All CD spectra were corrected for buffer, detergents, or lipid vesicle
contributions. Ellipticity is reported as mean molar residue ellipticity (MRE)
in degree-cm2-dmol1. The fractional contents of secondary structures,
namely a, b, and random coil, were calculated using the software CDPro
(15). The wavelength used for the analysis was 195–260 nm, and 29 soluble
proteins constituted the reference set. The per residue molar absorption units
of circular dichroism De, which is measured in mdeg-M1-cm1, is related
to MRE by De ¼ MRE/3298. The calculated fractions of each secondary
structure element from all three programs included in CDPro (CONTIN,
SELCON3, and CDSSTR) were ﬁrst averaged, then the averaged fractions
of H(r) (regular a-helix) and H(d) (distorted a-helix), S(r) (regular b-strand)
and S(d) (distorted b-strand), and T (turns) and U (unordered) were used to
give the overall content of a, b, and random structure (g), respectively.
Intrinsic ﬂuorescence spectroscopy
Fluorescence emission spectra of hP0-cyt Trp residue were obtained using a
HORIBA Jobin Yvon Spex Fluorolog II spectroﬂuorimeter (Edison, NJ) and
1 cm path-length quartz cuvette (Starna Cells, Atascadero, CA,) by exciting
samples at 295 nm. Excitation and emission slits were set at 5 mm and data
were collected at 0.5 nm increments from 310 nm to 410 nm at 25C. The
control spectra without protein were collected as baselines and were sub-
tracted from the corresponding spectra of samples having protein concen-
trations of 5 mM. The following equation was used to correct the spectra
from SUV samples for the inner-ﬁlter effect resulting from the strong ab-
sorbance of lipid vesicles at both emission and excitation wavelengths (16):
Fc ¼ Fm 3 10ðAem1AexÞ=2:
Here, Fc is the corrected ﬂuorescence intensity, Fm is the measured
ﬂuorescence intensity after background subtraction, and Aem and Aex are
the absorbances at the emission and excitation wavelengths, respectively
(17,18).
RESULTS
hP0-cyt conformation depended on detergent or
lipid/protein mole ratio
hP0-cyt is a highly basic domain (pI ¼ 10.88), containing 21
positive-charged residues (from 9 arginines and 12 lysines)
distributed across its entire sequence (Fig. 1 A). Secondary
structure predictions (19–21) indicated signiﬁcant amounts
of a-helix (Fig. 1 B). By contrast, our initial far UV-CD
spectrum suggested ,10% a and .35% b secondary struc-
tures when hP0-cyt was in an aqueous buffer (Table 1).
When the protein was mixed with different membrane-
mimicking detergents (DPC, SDS, and TFE), an increase in
ellipticity at both 222 nm and 208 nm in the CD spectra,
which is typical of an a-helical structure (22), was observed
in a detergent-concentration-dependent manner (Fig. 2,
A–C). In 2 mM DPC, which is equal to 100:1 mol ratio of
DPC:hP0-cyt, a-helical structure increased to ;40% and
b-structure decreased to ,20% (Fig. 3 A), while at the same
100:1 mol ratio of SDS/protein, hP0-cyt underwent a greater
conformational change, with close to 60% a and ,5%
b-structure (Fig. 3 B). At all concentrations tested, TFE also
effectively induced protein folding to an a-helical structure
and decreased the amount of b-structure (Fig. 3 C). The
observed b/a transition of hP0-cyt structure induced by
these detergents encouraged us to explore the structural
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features of hP0-cyt in an environment more closely related to
its native conditions—i.e., the myelin membrane.
As total lipid extracts of myelin contain lipids not present
in the cytoplasmic leaﬂet, we used lipids that would be more
akin to the native environment of P0-cyt. We produced lipid
SUVs using mixtures of PC/PS, or PC/PS/cholesterol, all
of which are thought to be important constituents in the
cytoplasmic surface of peripheral nervous system myelin
(23). Interestingly, similar to that from protein in aqueous
buffer, CD spectra of hP0-cyt in PC/PS vesicles suggested a
predominant b-structure at lipid/protein ratios ,50:1 (the
level of the mature peripheral myelin), but underwent a
concentration-dependent b/a transition at lipid/protein
ratios.50:1 (Fig. 2, D and E). Noticeably, when cholesterol
was added to PC/PS, the transition from b/a structure of
hP0-cyt occurred at lower lipid/protein mole ratio and in a
more dramatic way than observed in the absence of choles-
terol. Speciﬁcally, in vesicles made of PC/PS/cholesterol,
hP0-cyt showed .20% a and ,30% b-structures at 20:1
lipid/protein mole ratio, while at the same lipid/protein ratio,
,10% a and .30% b-structures were maintained in PC/PS
vesicles lacking cholesterol. Interestingly, when the lipid/
hP0-cyt molar ratio is .20:1, both a and b contents of the
protein start to decrease in vesicles containing cholesterol,
which was not observed in the absence of cholesterol (Fig. 3,
D and E). This difference in structural changes might
indicate certain functions of cholesterol in hP0-cyt structure
in the myelin membrane. Coupled with the conformational
change in these different membrane-like environments is a
rather limited change in random structure of hP0-cyt (Fig. 3).
This indicates that the observed conformational change
might be happening primarily between b- and a-conforma-
tions rather than involving unstructured regions.
Negative-charged vesicle lipids had little effect
on the secondary structures of hP0-cyt
As hP0-cyt is highly basic, vesicles composed of only
negative-charged PS were used to investigate whether the
vesicle-induced structural change in hP0-cyt might result
from electrostatic interactions between the protein and
phospholipid headgroups (Fig. 4 A). CD spectra for PS/
hP0-cyt mole ratio from 4 to 100:1 revealed a nearly constant
protein secondary structure with ,10% a, 30–40% b, and
;60% random coil (Fig. 3 F). Similarly, vesicles made of
only PI, another negative-charged lipid on the cytoplasmic
surface of peripheral nervous system myelin, had very little
effect on the secondary structure of hP0-cyt (Fig. 4 B). These
results strongly argue that the negative charge of vesicle
lipids might not be the driving force of the observed b/a
structural transition at lipid/protein ratios above that in
mature peripheral myelin.
N-terminal tryptophan microdomain became more
folded in membrane-like environments
To investigate whether these membrane mimetics change the
tertiary structure of the N-terminal tryptophan micro-domain,
FIGURE 1 Sequence of hP0-cyt (A) and its secondary structure (B) predicted according to Chou-Fasman, JPred, and PROF (19–21). ED, P0 extracellular
domain; TM, P0 transmembrane domain; Cyt, P0 cytoplasmic domain. hP0-cyt contains 69 residues (151–219) and is highly basic, with a net charge of 115,
pl ¼ 10.88. H, a-helix; e, b-strand; t, turns.
TABLE 1 Calculated secondary structure and a-b
equilibrium constants for hP0-cyt (in PBS) at different
protein concentrations
hP0-cyt (mM) in PBS 20 mM 50 mM 100 mM 250 mM
a 0.06 0.10 0.21 0.21
b 0.36 0.38 0.25 0.22
g 0.58 0.52 0.54 0.57
Kab 6.00 3.80 1.19 1.05
s (mM1)* 10 6 11 5
The amount of secondary structure was calculated using CDPro.
*The value s was calculated according to s ¼ ð1 ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃb=ð1 gp Þ=Ptb.
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we used intrinsic ﬂuorescence spectroscopy. For all mem-
brane conditions tested, we observed a consistent lipid or
detergent-concentration-dependent blue shift in the ﬂuores-
cence emission maximum and an increase in ﬂuorescence
intensity compared with the spectrum of hP0-cyt in aqueous
bulk phase (Fig. 5). This ﬁnding suggests that in membrane
environments the N-terminal tryptophan of hP0-cyt is
oriented away from the polar, aqueous phase toward a
more hydrophobic region—presumably the nonpolar regions
of the membrane. This conformational change might have
FIGURE 2 CD spectra of hP0-cyt at 20 mM in different membrane environments. CD spectra of hP0-cyt in simple membranes made of membrane-
mimicking compounds DPC (A), SDS (B), and TFE (C), or in lipid SUVs made of PC/PS (mole ratio 12:1) (D), or PC/PS/cholesterol (mole ratio 62:5:33) (E)
are recorded at different compound concentrations or lipid/protein mole ratios. SUV samples of different lipid/protein mole ratios 0, 4:1, 20:1, 50:1, 100:1, and
200:1, are designated as PBS, SUV4, SUV20, SUV50, SUV100, and SUV200, respectively.
FIGURE 3 Plots of calculated secondary structure of hP0-cyt in different membranes. Secondary structure fractions calculated from CDPro program were
plotted as a function of concentration of membrane-mimicking compound or lipid/protein mole ratio. Symbols: s, a; h, b; n, random coil.
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important implications in the folding behavior of hP0-cyt in a
native environment.
bMBP secondary structure did not change in
lipid vesicles
To test whether the observed b/a structural transition of
hP0-cyt is a common characteristic of basic proteins in
membrane environments, similar CD experiments were
conducted using the 18.5 kDa isoform of bMBP, another
highly positive-charged myelin protein (calculated pI ¼
11.4; (23)) that is believed to be important in the compaction
of myelin’s cytoplasmic apposition. Our data showed that in
vesicles composed of either PC/PS or PC/PS/cholesterol,
bMBP did not show a similar lipid/protein ratio-dependent
b/a conformational change as observed for hP0-cyt, but
FIGURE 4 CD spectra of hP0-cyt in SUVs made of
only negative-charged lipid PS (A) or PI (B), and the
18.5 kDa bovine MBP isoform in lipid SUVs made
of PC/PS (mole ratio 12:1) (C), or PC/PS/cholesterol
(mole ratio 62:5:33) (D).
FIGURE 5 Fluorescence emission spectra of hP0-cyt at 5 mM in different membrane environments. Trp-speciﬁc ﬂuorescence emission spectra of hP0-cyt in
the same experimental conditions as shown in Fig. 2 were recorded and lipid/protein mole ratios of SUV samples were designated in the same way. Fluo-
rescence intensity (IF) is presented in arbitrary units (A.U.).
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maintained a similar distribution of secondary structures as
bMBP did in aqueous buffer (Fig. 4, C and D; Table 2). Like
hP0-cyt, bMBP also showed little change in secondary
structures in the presence of only negative-charged lipids, PS
or PI (Table 2). These results collectively suggest that the
structural characteristics of hP0-cyt in a membrane environ-
ment might be a novel feature, and not due simply to a charge
effect.
DISCUSSION
The notion that the highly basic cytoplasmic domain of
myelin P0 glycoprotein interacts with acidic lipids at the
cytoplasmic apposition in myelin (24) is questioned by our
previous x-ray diffraction studies that reveal relative invari-
ance of the intermembrane space at this apposition over a
wide range of pH and ionic strength (9,11). Thus, electro-
static interactions cannot solely account for the cytoplasmic
apposition in peripheral nervous system myelin. In the
current study, which used a membrane-mimetic system, we
demonstrated that negative-charged lipids (PS or PI) did not
induce signiﬁcant change in P0-cyt secondary structure,
whereas in PC/PS vesicles at lipid/protein ratios at or lower
than that of mature peripheral myelin, P0-cyt primarily
adopted a b-sheet structure. Such mole ratios resemble that
in compact myelin, where the relative P0 content is higher
than that during earlier stages of myelin synthesis. Therefore,
we suggest that P0-cyt likely adopts a similar b-structure in
compact myelin where strong intersheet H-bonding could
largely account for the stability of the narrow cytoplasmic
apposition.
Structural polymorphism of hP0-cyt dependent on
lipid/protein mole ratio
Our results show that in PC/PS vesicles hP0-cyt undergoes a
b/a structural transition at lipid/protein mole ratios higher
than that of mature peripheral myelin. Curiously, a similar
conformational change is observed for amyloidogenic protein
Ab40 with phosphoglycerol, Ab40 with PC 1 phosphogly-
cerol (25), and Ab40 with ganglioside-containing mem-
branes (26).
The secondary structure contents were calculated as a
function of the lipid/protein mole ratio Lt/Pt. The a-b equi-
librium Kab (see Appendix) was calculated from the second-
ary structure contents as determined using the CDPro program
for hP0-cyt in the absence of lipids. From our observed
secondary structure contents of 20 mM hP0-cyt in aqueous
buffer, a ¼ 0.06, b ¼ 0.36, and g ¼ 0.58. Kab was thus
estimated to be 6.0 (Table 1). The equilibrium constants
for different concentrations of hP0-cyt in PBS are given in
Table 1.
Concentration-dependent b!a transition in
hP0-cyt structure
In our CD measurements, the hP0-cyt structure showed a
b/a transition and a nearly constant random structure as a
function of the protein concentration in aqueous buffer (Fig.
6 and Table 1). The dramatic increases in a structure of hP0-
cyt in DPC, SDS, and TFE indicate that the protein is in-
corporated into DPC and SDS micelles, or in the lower
dielectric environment of TFE where the a-helix is stabilized
(27). Therefore, at higher concentration hP0-cyt may interact
with neighboring protein molecules in aqueous buffer in a
similar way as in detergents (see Appendix).
Although we did not observe a transition from random coil
to b as a function of hP0-cyt concentration from 20–250
mM, such a transition may occur at an even lower concentra-
tion as has been observed for Ab25–35 at pH 4.0 (28). There-
fore, depending on its concentration, hP0-cyt may form three
different conformations—i.e., random coil / b at 0–20
mM, b/a at .20 mM, and constant random coil content
at .20 mM.
Similarity in secondary structures between
amyloidogenic peptides and hP0-cyt in lipids
Studies on the interactions between membranes and amyloid-
ogenic proteins—including Alzheimer’s b-amyloid protein
(25,26,28–35), amylin (36), and calcitonin (37)—have sought
to explain the role of biological membranes in mechanisms of
amyloid assembly. The interactions between small antimi-
crobial peptides with membranes have also been studied to
investigate therapeutic mechanisms (38). Whereas the im-
munoglobulin fold (common to certain adhesion proteins)
and domain-swapping (which could also underlie adhesion)
have been characterized using crystallography (10), the inter-
actions of simple lipid systems with peptide fragments of
myelin proteins have not been explored.
TABLE 2 Calculated secondary structure of 18.5 kDa bovine MBP in SUVs at different lipid/protein mole ratios
Calculated
structure
PC/PS PC/PS/cholesterol PS PI
PBS 4 20 50 100 4 20 50 100 4 20 50 100 4 20 50 100
a 0.02 0.06 0.03 0.02 0.00 0.04 0.03 0.03 0.00 0.04 0.02 0.03 0.03 0.02 0.04 0.05 0.05
b 0.41 0.38 0.37 0.40 0.45 0.49 0.49 0.48 0.54 0.54 0.54 0.62 0.39 0.51 0.49 0.40 0.50
Random 0.57 0.56 0.60 0.58 0.55 0.47 0.48 0.49 0.46 0.42 0.44 0.35 0.58 0.47 0.47 0.55 0.45
Lipid/protein mole ratios are 4:1, 20:1, 50:1, and 100:1. The fractional amount of secondary structure was calculated using CDPro.
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For fragments of membrane protein, the peptides can show
changes in either conformation or assembly, depending on
the lipid/protein mole ratio, the speciﬁc lipid species, and the
solvent system. Antimicrobial peptides at low concentration
adopt either an a-helical or b-strand conformation with
helix- or strand-axis parallel to the membrane surface, but the
axes become more normal to the surface and transmembrane
at higher protein concentration (38). In the presence of lipids,
the amyloidogenic peptides Ab25–35 and Ab40 show a ran-
dom coil/b transition and a moderate increase in a-helix
as a function of protein concentration (probably due to elec-
trostatic effects). The random coil/b transition occurs at
lower lipid/protein ratios, whereas the b/a transition oc-
curs at higher ratios (25,28,30,33,36). As GM1 ganglioside
speciﬁcally enhances the random coil/b transition, it might
be involved in pathological Ab aggregation (26,29,35). Ab
as an a-helix is observed at higher lipid/protein ratios, and
can be either normal to (39) or parallel to (25,26) the mem-
brane surface. The former is consistent with ion channel
formation (40). In addition, the amyloidogenic prion protein
PrP106-126 exhibits structural polymorphism among ran-
dom coil, b-sheet, and a-helix depending on the presence of
detergents and lipid vesicles (13).
We showed that ;20 mM hP0-cyt in aqueous buffer gave
a signiﬁcant amount of random coil and b-conformation and
relatively little a-content, while hP0-cyt at ,20 mM might
contain more random coil, like the case for amyloidogenic
peptides. With an excess of negative-charged lipid (PS), sig-
niﬁcant amounts of b and little awere found, suggesting that
electrostatic effects may stabilize the b-sheet assembly as it
does for Ab amyloid (25). With vesicles made of PC/PS or
PC/PS/cholesterol at lipid/protein mole ratios of 50:1 or
higher, however, a decrease in b-conformation for hP0-cyt
was observed. As the calculated mole ratio for the cytoplasmic
surface of intact peripheral nervous system myelin is 54:1
(23), hP0-cyt might be considered to be at a setpoint for con-
formational transition near this ratio. Moreover, the increase
in folding of the N-terminal, tryptophan-containing micro-
domain in our model membranes indicates that some resi-
dues (including the tryptophan) of hP0-cyt may be embedded
in the hydrocarbon chain region of the membranes.
hP0-cyt and amyloidogenic proteins appear to have
similar b-conformation secondary structures at lipid/protein
ratios ,;50:1 (25). Thus, H-bonding between b-chains
of hP0-cyt may contribute to the stability of the cytoplasmic
apposition between myelin membranes across a wide range
of pH and ionic strength.
Implication of structural polymorphism of hP0-cyt
in myelin development
The lipid/protein ratio-dependent conformational change in
hP0-cyt might indicate a dynamic change in structure during
critical developmental stages in myelin formation. In early
stages of myelin synthesis when only small amounts of P0 are
incorporated into the membranes, the lipid/protein ratio is
high and P0-cyt might be primarily a-helical. In the immature
myelin environment, an a-helical structure may allow for
more ﬂexibilitywithin the cytoplasmic apposition, facilitating
the transport of crucial materials within this narrowing space.
An a-helical structure for P0-cyt might also promote signal
transduction, which is consistent with the study on the
phosphorylation of the serine residue in the ‘‘RSTK’’ PKC
recognition site in this domain (Fig. 1) (41). At this stage, the
N-terminal Trp residue of the cytoplasmic domain together
with the acyl chain that is attached to the adjacent Cys residue
(42) may serve as anchors that stabilize the helical structure,
as shown in recent ﬂuorescence spectroscopy (43,44) and
simulation studies (45,46). At later stages of myelination,
when more P0 molcules insert into the membrane and there is
less relative lipid, P0-cyt would undergo the a/b transition
thus facilitating compaction at the cytoplasmic apposition via
intersheet H-bonding.
The water content in the cytoplasmic apposition of myelin
is;30–40% (23), which is considerably less than the excess
water in solutions containing unilamellar vesicles. Owing to
this difference and to other factors in the myelin microenvi-
ronment, the protein conformation may change as the space
between apposed membranes narrows during myelination,
similar to what we propose here for hP0-cyt. The CD and
ﬂuorescence methods in this study necessitated the use of
adequate protein and lipid concentrations for measurement
but in optically transparent solutions; therefore, the confor-
mation of hP0-cyt at lower water content could not be de-
termined using solution spectroscopy. By changing the lipid/
protein ratio, however, we attempted to use a simple paradigm
to mimic the dynamic change in the corresponding constit-
uents duringmyelin development. In early myelination stages,
when the cytoplasm of Schwann cells has not yet been ex-
pelled from the myelin sheaths, a signiﬁcant amount of water
should remain between cytoplasmic faces in an array of mye-
lin membranes. Therefore, samples having high lipid/protein
ratios may, in fact, closely simulate the native conditions.
FIGURE 6 CD spectra of hP0-cyt at different concentrations in PBS.
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We propose that hP0-cyt adopts a b-conformation in
compact PNS myelin, and that intersheet H-bonding of the
apposed hP0-cyt molecules stabilizes the cytoplasmic appo-
sition. This model can account for both the observed narrow
cytoplasmic apposition and also the invariance of this
apposition at different values of pH and ionic strength. The
model also explains the lack of conformational change in
hP0-cyt when it interacts with acidic lipids, as observed in
our current study.
Implication of cholesterol-induced conformational
change in hP0-cyt
The very high level of cholesterol in myelin (47) is thought to
limit ion leakage (48) and thus enhance the high resistance
and low capacitance of the myelin sheath in its insulative
role. Further, cholesterol forms lipid rafts with glycosphin-
golipids and certain membrane proteins (49), and in periph-
eral nervous system myelin, it associates with substantial
amounts of peripheral myelin protein 22 (PMP22) and P0
in the rafts (50). In our study, we observed an unexpected
structural change in hP0-cyt when the protein was mixedwith
vesicles containing cholesterol—i.e., at lipid/protein mole
ratio ,20:1, the a-helix secondary structure increased and
b and random coil decreased, whereas at higher mole ratios,
both a- and b-structures decreased and the random coil
content increased (Fig. 3 E). The threshold lipid/protein mole
ratio of;20 corresponds to cholesterol/protein mole ratio of
6.6 in the vesicle. Therefore, it is likely that cholesterol
interacts with hP0-cyt in a concentration-dependent manner.
At ratios,6.6, cholesterol favors the folding of hP0-cyt into
an a-helical structure, presumably by speciﬁcally stabilizing
this conformation. The a-helix-inducing property of choles-
terol is suggested by our CD data, which show a more rapid
b/a conformational change in hP0-cyt compared with the
protein in vesicles lacking cholesterol but having the same
lipid/protein ratio (Fig. 3 D). This result is also consistent
with previous reports suggesting that the addition of 33%
cholesterol to artiﬁcial membranes induces a b/a transition
of Ab40 (51,52). Intriguingly, in our current report, at mole
ratios .6.6, cholesterol seems to unfold the protein into a
random coil. Further experiments using lipid vesicles con-
taining varying amounts of cholesterol may help to shed
more light on this unique phenomenon.
b-conformation of MBP at cytoplasmic apposition
Unlike hP0-cyt, MBP did not show a b/a conformational
change as a function of lipid/protein ratio. Rather, at ratios
at least up to 100:1, 50% b and 8% a-helix were always
observed. Since the lipid/MBP mole ratio at the cytoplasmic
side of central nervous system myelin is estimated to be;48
(23), the consistently high b-content of MBP at different
lipid/MBP ratios suggests that the b-sheet conformation
might be required for this protein to be involved in the
membrane apposition. Studies on the MBP-deﬁcient ‘‘shiv-
erer’’ mouse demonstrate that MBP is needed for myelin
compaction in the central nervous system (53) but not in the
peripheral nervous system (5). This difference may be ex-
plained by the presence in peripheral nervous system myelin
of P0 whose basic cytoplasmic domain plays a compensatory
structural role for the missing MBP. In reconstituted mem-
branes consisting of myelin lipids and basic proteins, x-ray
diffraction analysis has localized the proteins in the regions
that contain aqueous medium and lipid polar headgroups
(54–56). Small-angle x-ray scattering of MBP in solution
also indicates that its molecular shape is mainly random coil
but with lipids, it converts to a C-shaped structure rich
in b-sheet (57–59). A similarly-shaped structure is also
shown by electron microscopy (60,61). The preponderance
of b-conformation is consistent with earlier molecular mo-
deling (62,63), spectroscopy (64), and with x-ray diffraction
from solubilized and dried MBP, which shows typical
b-sheet reﬂections (65). Our current CD ﬁndings also sup-
port the notion for an adhesive role of b-sheet folded MBP at
the cytoplasmic apposition. Unlike hP0-cyt whose confor-
mation depended on the type and relative amount of lipids
present, bMBP always showed b-sheet structure indepen-
dent of lipid concentration (Fig. 4, C and D; Table 2). Mole-
cular modeling indicates that the interstrand H-bonding
direction of MBP molecules is likely to be normal to the
membrane surfaces (Fig. 7, right).
Comparison with previous studies on
MBP conformation
Previous CD studies of MBP reported random conformation
for the protein in aqueous solution, but a- and b-structures
with lipids present (66). Convex constraint analysis has been
used to calculate the secondary structure content of MBP in
aqueous media with or without lipids (66,67). Results from
three samples were reported: lipid-free MBP (LF-MBP); LF-
MBP with 0.5% CHAPS; and lipid-bound MBP (LB-MBP)
with 0.5% CHAPS in 10 mM HEPES buffer at pH 8. LF-
MBP and LF-MBP with CHAPS showed 5–9% a, 6–7% b,
;50% random coil, and;30–40%b-turn, whereas LB-MBP
with CHAPS showed ;20% a, ;20% antiparallel b-sheet,
;30% random coil, and;30% b-turn. From analysis of TLC
plates, the MBP-bound lipids contained 26% cholesterol,
6.5% cerebrosides, 8% sulfatides, 32.6% phosphatidyletha-
nolamine, 5.2% PI, 4.3% PS, 15.6% PC, and 3.5%
sphingomyelin (SM). The minimum lipid content of MBP
after dialysis was 1.5 mg phospholipid/mg protein. Assuming
the reported percentage refers to weight content, then the
molar contents may be calculated from the molecular masses
of the respective lipids. As 1 mg of MBP corresponds to
0.054 mmol, then the molar ratio of total lipid to 18.5 kDa
MBP is 2.03:0.054 ¼ 38. This is smaller than the estimated
ratio of 48 for lipid/MBP on the cytoplasmic side of CNS
myelin (23). The measured molar contents of MBP-bound PS
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and cholesterol were less than those estimated from the
chemical composition data (23). The two different measure-
ments, however, show similar contents of the other lipids.
The CD spectra for native and recombinant 18.5 kDa
MBP with or without GM1 and 2-propanol have been
determined (66). Native and recombinant MBP in aqueous
solution gave ;10% a and 16–18% b, which were greater
than those calculated for LF-MBP (67). GM1 increased the
a- and b-contents slightly to ;13% and ;17–20%, respec-
tively, while 2-propanol increased them more to ;28–34%,
and ;21–24%, which are comparable to those of LB-MBP
calculated (67).
The secondary structure content of MBP calculated using
the convex constraint analysis program (see above) are dif-
ferent from the ones we measured for MBP in PBS solution
using the CDPro program, i.e., 2% a, 41% b, and 57%
random coil (Table 2). In the previous experiments, MBPwas
extracted from bovine brain white matter and puriﬁed in the
lipid-free, denatured form or endogenous lipid-bound form
(67); by contrast, we used commercial dephosphorylated
bovine 18.5 kDaMBP. The difference in sample preparations
may greatly inﬂuence the solution conformation of MBP.
Alternatively, as PC/PS, PC/PS/cholesterol, and negative-
charged PS and PI did not increase the a-content in our study,
it may be that other lipids (phosphatidylethanolamine or small
amounts of glycolipids) in the tightlyMBP-bound formmight
stabilize the a-conformation of MBP just as 2-propanol
increased the a-contents for MBP (66). For Ab amyloid
protein (51) and hP0-cyt (this study), cholesterol appears
to increase the a-helical content. As this was not observed
for MBP with PC/PS/cholesterol, the interaction between
MBP and cholesterol is different from that involving Ab or
P0-cyt.
Comparison of the different reference sets in
CDPro program
In the software program CDPro there are different reference
sets available, including 29 soluble proteins (SP29), 43
soluble plus ﬁve denatured proteins (SDP48), and 43 soluble
plus 13 membrane proteins (SMP56) (15,68–70). The origi-
nal set (SP29; measured wavelength range 178–260 nm) was
the only reference set that covered the entire experimental
wavelength range of our CD spectra (195–260 nm) and was,
therefore, used here for data analysis.
Owing to their large content of random coil, both hP0-cyt
and MBP can be regarded as intrinsically disordered pro-
teins. In addition, both hP0-cyt and MBP are membrane-
bound proteins. Secondary structures of these types of
proteins, therefore, might be better predicted by using
reference sets SDP48 or SMP56. We compared the perfor-
mances of these reference sets in terms of the root mean-
square deviation (RMSD) values between the observed and
calculated CD spectra for hP0-cyt in PBS, hP0-cyt with PC/
PS at 200 lipid/protein ratio, and MBP in PBS (see Table in
the Supplementary Material). All three methods in CDPro,
CONTINLL, SELCON3, and CDSSTR generated results
when SP29 was used as a reference set. For SPD48,
SELCON3 did not yield results for hP0-cyt in PBS or for
MBP in PBS; and for the SMP56 set, CDSSTR did not give
results for MBP. Comparing the RMSD values among the
three methods, SELCON3 gave the smallest RMSD values
for all three samples using the SP29 set; CDSSTR gave the
smallest values for hP0-cyt in PBS and MBP in PBS using
the SDP48 set; and CONTINLL gave the smallest value for
hP0-cyt in PC/PS vesicles using the SMP56 set. As the SP29
set gave the best overall performance among the three refer-
ence sets, then we suggest that, in our current studies, this
reference set gave reasonably accurate measurements for the
secondary structures of hP0-cyt and MBP.
Possible a- and b-chain domains for hP0-cyt
Secondary structure predictions indicated that most of the
residues in the cytoplasmic domain of P0 are in an a-helix
and that residues 37–39 (ThrProVal) are in a b-conformation
(19–21). This predicted b-sequence is part of a single
long stretch of hydrophobic residues (sequence 37–44;
TPVLYAML) that is bounded at its N-terminus by Gln-36
and at its C-terminus by Asp-45 (Fig. 1 B). Structure-based
homology searching with 3D-PSSM (71) predicted that
hP0-cyt might have a compact structure similar to that for
bacteriophage-l gpw (PDB No. 1HYW) in solution (Fig. 7,
left). In this study we predicted that the hydrophobic
sequence 39–44 (VLYAM) has an extended b-chain, which
is conserved for all species except trout and zebraﬁsh. It is
FIGURE 7 Molecular models for hP0-cyt (left) andMBP
(right) from the atomic coordinates deposited in PDB data
bank (Entry No. 1qcl). In hP0-cyt a short hydrophobic
sequence V39LYAM43 is indicated by the stippling. The
other b-chain is formed by residues G27KDA30. In both
hP0-cyt and MBP molecules, the intersheet H-bonding
direction is likely to be normal to the membrane surfaces,
i.e., parallel to the membrane-stacking direction. The rib-
bon representations were generated using PyMOL (74).
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likely that this hydrophobic short sequence may nucleate the
b-sheet folding for the cytoplasmic domain of P0 when
in the appropriate membrane environment. The observed
conformational ﬂexibility that we have identiﬁed for hP0-cyt
may have a crucial role in regulating myelin packing.
APPENDIX
Quantitation of protein conformational change
that is dependent on lipid/protein ratio
Protein and lipid binding isotherms likely depend on the concentrations of
protein and lipids. Since there are three conformers, A (a), B (b), and R
(random, or g), and the conformational change is between a and b at given
protein and lipid concentrations, then the isotherm may be written as
A4B
A1 nL4ALn
B1mL4BLm:
Here, A and B are the free form of protein conformations a and b, L is lipid,
and ALn and BLm are the lipid-bound forms of the a- and b-conformations,
respectively. We assumed that there is no reaction between the lipid-bound
forms of proteins having different conformations. The total protein con-
centration is Pt ¼ [A] 1 [B] 1 [ALn] 1 [BLm] 1 [R]; and the lipid total
concentration is Lt ¼ L 1 n[ALn] 1 m[BLm]. The a-content is ([A] 1
[ALn])/Pt, the b-content is ([B] 1 [BLm])/Pt, and the random content g is
1(a1b). The mole ratio between lipid and protein is f ¼ Lt/Pt. The a-b
equilibrium reaction constants are deﬁned as Kab, kal, and kbl; therefore,
Kab ¼ ½B=½A
kal ¼ ½ALn=½A½Ln
kbl ¼ ½BLm=½B½Lm:
Then
Pt ¼ ½Að11Kabð11 ½LmkblÞ1 ½LnkalÞ1 ½R
Lt ¼ ½L1 nkal½A½Ln1mKabkbl½A½Lm
f ¼ Lt=Pt
a ¼ ½Að11 kal½L
nÞ
Pt
:
b ¼ Kab½Að11 kbl½L
mÞ
Pt
g ¼ ½R=Pt ¼ 1 ða1bÞ:
[A] and [L] can be derived numerically from the ﬁrst two equations by using
the known Pt, Lt, and reaction constants. The amounts of secondary structure
(a, b, and g) can be calculated from the last three equations. When lipids are
not mixed with protein, Lt ¼ L ¼ 0; and the equations simplify to
Pt ¼ ½Að11KabÞ1 ½R
f ¼ 0
a ¼ ½A
Pt
¼ Pt  ½R
Ptð11KabÞ ¼
1 g
11Kab
b ¼ aKab
g ¼ ½R=Pt ¼ 1 ða1bÞ:
Because the a-conformer increased at values above the physiological lipid/
protein mole ratio (in our experiments), we assumed that the binding con-
stant kal .. kbl, kbl ¼ 0, and lipid binding stoichiometry n ¼ 1; therefore,
Pt ¼ ½Að11Kab1 ½LkalÞ1 ½R
Lt ¼ ½Lð11 kal½AÞ
f ¼ Lt=Pt
a ¼ ½Að11 kal½LÞ
Pt
b ¼ Kab½A
Pt
g ¼ ½R=Pt ¼ 1 ða1bÞ:
[A] and [L] were solved analytically from the ﬁrst two of these equations.
The constant kal was determined by systematically changing its value to
ﬁt the observed a-content at different concentrations of PC/PS or PC/PS/
cholesterol vesicle lipids. The best kal values chosen were 2.4 mM
1 for
PC/PS and 7.6 mM1 for PC/PS/cholesterol, respectively (Fig. A1). The free
energy (DG) of lipid binding to an a-helical conformer in vesicles made of
PC/PS or PC/PS/cholesterol was calculated to be ;5 kcal/mol. Note in
PC/PS/cholesterol, the calculated curve did not ﬁt the entire range of mole
ratios, as the a-content increased and then decreased as a function of lipid/
protein mole ratio (Fig. A1, right).
FIGURE A1 (Left) Observed second-
ary structure contents (a (s) and b (h))
derived from CDPro and the calculated
ones (a (solid line) and b (dashed line)),
as a function of the PCPS/hP0-cyt mole
ratio. The input parameters for the
calculated curves included Kab ¼ 6.0,
kal ¼ 2.4 mM1, n ¼ 1, kbl ¼ 0, and
random structure content g ¼ 0.58.
The k value was an average of the best-
ﬁt observed a-contents at 100:1 and
200:1 lipid/protein mole ratios. (Right)
Secondary structure as a function of
PCPS-cholesterol/hP0-cyt mole ratio. The input kal was 7.6 mM
1 and other parameters were the same as those in PC/PS. The k value was an average
of those best-ﬁt observed a-contents at lipid/protein mole ratios of 20:1 and 50:1.
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Quantitation of protein aggregation and
protein conformational change based on
protein concentration
To quantify the concentration-dependent b/a transition of hPO-cyt in
aqueous buffer, we used a formulation similar to that for protein aggregation
(33,72,73), in which the a-conformer is treated as an aggregate. The total
concentration of the protein Pt is
Pt ¼ ½Bð1 s½BÞ21 ½R
s ¼ 1
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ½B=ðPt  ½R
p Þ
½B ;
where [B] is the concentration of the b-form, s is the binding constant for the
addition of the b-form to the self-aggregate, and [R] is the concentration of
the random form. The a-content is
a ¼ Pt  ½B  ½R
Pt
:
We assumed that the content of random coil was constant for different total
protein concentrations. From these equations, the contents of the secondary
structures were calculated as a function of protein concentration. For ex-
ample, the binding constant s for the respective concentration was estimated
(Table 1), and the average value was found to be 8 mM1, which cor-
responds to a free energy DG ¼ –5 kcal/mol for addition of b-conformer.
The calculated curve was derived from the average values of s ¼ 8 mM1,
and the random structure content 0.55 (Fig. A2).
At ,20 mM, the secondary structure content of hP0-cyt could be
accounted for by the binding of monomer (in a random conformation) to
aggregate (in a b-conformation). By comparison, the binding constant mea-
sured for Ab25–35 in the noncooperative model is 18 mM1 (28), which is
similar to the one we measured here for the b/a transition of hP0-cyt.
SUPPLEMENTARY MATERIAL
An online supplement to this article can be found by visiting
BJ Online at http://www.biophysj.org.
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